{"id":"https://openalex.org/W2254036934","doi":"https://doi.org/10.1186/s12944-016-0197-4","title":"Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo","display_name":"Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo","alternate_titles":[],"publication_year":2016,"publication_date":"2016-02-13","ids":{"openalex":"https://openalex.org/W2254036934","doi":"https://doi.org/10.1186/s12944-016-0197-4","mag":"2254036934","pmid":"https://pubmed.ncbi.nlm.nih.gov/26872608","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4752766"},"language":"en","primary_location":{"id":"doi:10.1186/s12944-016-0197-4","doi":"https://doi.org/10.1186/s12944-016-0197-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12944-016-0197-4","pdf_url":"https://lipidworld.biomedcentral.com/track/pdf/10.1186/s12944-016-0197-4","source":{"id":"https://openalex.org/S188748365","display_name":"Lipids in Health and Disease","issn_l":"1476-511X","issn":["1476-511X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids in Health and Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2254036934"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://lipidworld.biomedcentral.com/track/pdf/10.1186/s12944-016-0197-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054876477","display_name":"Peter Paul Toth","orcid":"https://orcid.org/0000-0001-5810-5460","observed_orcids":["https://orcid.org/0000-0001-5810-5460"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210120111","display_name":"CGH Medical Center","ror":"https://ror.org/02vajn858","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120111"]},{"id":"https://openalex.org/I4210130227","display_name":"Peoria campus of the University of Illinois System","ror":"https://ror.org/02qrdc062","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238","https://openalex.org/I4210130227"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter P. Toth","raw_affiliation_strings":["CGH Medical Center, 101 East Miller Rd, Sterling, Illinois, 61081, USA. peter.toth@cghmc.com","Johns Hopkins University School of Medicine, Baltimore, MD, USA. peter.toth@cghmc.com","University of Illinois School of Medicine, Peoria, IL, USA. peter.toth@cghmc.com","CGH Medical Center, 101 East Miller Rd, Sterling, Illinois, 61081, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CGH Medical Center, 101 East Miller Rd, Sterling, Illinois, 61081, USA. peter.toth@cghmc.com","institution_ids":["https://openalex.org/I4210120111"]},{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, MD, USA. peter.toth@cghmc.com","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"University of Illinois School of Medicine, Peoria, IL, USA. peter.toth@cghmc.com","institution_ids":["https://openalex.org/I4210130227"]},{"raw_affiliation_string":"CGH Medical Center, 101 East Miller Rd, Sterling, Illinois, 61081, USA","institution_ids":["https://openalex.org/I4210120111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019163181","display_name":"Sara Hamon","orcid":"https://orcid.org/0000-0002-2413-2302","observed_orcids":["https://orcid.org/0000-0002-2413-2302"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sara C. Hamon","raw_affiliation_strings":["Regeneron, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076662257","display_name":"Steven Richard Jones","orcid":"https://orcid.org/0000-0002-5707-0021","observed_orcids":["https://orcid.org/0000-0002-5707-0021"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven R. Jones","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014267007","display_name":"Seth Shay Martin","orcid":"https://orcid.org/0000-0002-7021-7622","observed_orcids":["https://orcid.org/0000-0002-7021-7622"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seth S. Martin","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018577838","display_name":"Parag H. Joshi","orcid":"https://orcid.org/0000-0001-7863-2794","observed_orcids":["https://orcid.org/0000-0001-7863-2794"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Parag H. Joshi","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, MD, USA","University of Texas Southwestern Medical Center, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110198745","display_name":"Krishnaji R. Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Krishnaji R. Kulkarni","raw_affiliation_strings":["Atherotech, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atherotech, Birmingham, AL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077276053","display_name":"Poulabi Banerjee","orcid":"https://orcid.org/0000-0001-5304-9543","observed_orcids":["https://orcid.org/0000-0001-5304-9543"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Poulabi Banerjee","raw_affiliation_strings":["Regeneron, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108225270","display_name":"Corinne Hanotin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Corinne Hanotin","raw_affiliation_strings":["Sanofi, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Paris, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089409959","display_name":"Eli M. Roth","orcid":"https://orcid.org/0000-0002-3367-5704","observed_orcids":["https://orcid.org/0000-0002-3367-5704"]},"institutions":[{"id":"https://openalex.org/I4210090186","display_name":"Sterling Research Group","ror":"https://ror.org/009prea33","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210090186"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eli M. Roth","raw_affiliation_strings":["The Sterling Research Group, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Sterling Research Group, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I4210090186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054320288","display_name":"James M. McKenney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James M. McKenney","raw_affiliation_strings":["Virginia Commonwealth University, Richmond, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5054876477"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210120111","https://openalex.org/I4210130227"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":4.0879,"has_fulltext":true,"cited_by_count":52,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94933797,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"15","issue":"1","first_page":"28","last_page":"28"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alirocumab","display_name":"alirocumab","score":1.0},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/lipoprotein-subfractions","display_name":"lipoprotein subfractions","score":0.9330000281333923},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6769999861717224},{"id":"https://openalex.org/keywords/atherogenic-lipoproteins","display_name":"atherogenic lipoproteins","score":0.8659999966621399},{"id":"https://openalex.org/keywords/remnant-lipoproteins","display_name":"remnant lipoproteins","score":0.8410000205039978},{"id":"https://openalex.org/keywords/apolipoprotein-c-ii","display_name":"apolipoprotein C-II","score":0.7829999923706055},{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.9980000257492065},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9750000238418579},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2780902209","wikidata":"https://www.wikidata.org/wiki/Q4726914","display_name":"Alirocumab","level":5,"score":0.986790657043457},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.7825453281402588},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7162831425666809},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5869853496551514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5751662850379944},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.5266620516777039},{"id":"https://openalex.org/C22894154","wikidata":"https://www.wikidata.org/wiki/Q15483409","display_name":"Lipidology","level":3,"score":0.4990212917327881},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.49616512656211853},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.49389153718948364},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4842362105846405},{"id":"https://openalex.org/C382228","wikidata":"https://www.wikidata.org/wiki/Q849994","display_name":"Clinical chemistry","level":2,"score":0.4815097749233246},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.46692416071891785},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.43639639019966125},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3298496603965759},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.15878090262413025},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.07718291878700256},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06340223550796509},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008075","descriptor_name":"Lipoproteins, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008079","descriptor_name":"Lipoproteins, VLDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1186/s12944-016-0197-4","doi":"https://doi.org/10.1186/s12944-016-0197-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12944-016-0197-4","pdf_url":"https://lipidworld.biomedcentral.com/track/pdf/10.1186/s12944-016-0197-4","source":{"id":"https://openalex.org/S188748365","display_name":"Lipids in Health and Disease","issn_l":"1476-511X","issn":["1476-511X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids in Health and Disease","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4752766","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4752766/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids Health Dis","raw_type":"Text"},{"id":"pmid:26872608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26872608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids in health and disease","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1186/s12944-016-0197-4","doi":"https://doi.org/10.1186/s12944-016-0197-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12944-016-0197-4","pdf_url":"https://lipidworld.biomedcentral.com/track/pdf/10.1186/s12944-016-0197-4","source":{"id":"https://openalex.org/S188748365","display_name":"Lipids in Health and Disease","issn_l":"1476-511X","issn":["1476-511X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids in Health and Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310145","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95"},{"id":"https://openalex.org/F4320310431","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312852","display_name":"University of Alabama","ror":"https://ror.org/03xrrjk67"},{"id":"https://openalex.org/F4320315027","display_name":"Amarin Corporation","ror":"https://ror.org/02fccce66"},{"id":"https://openalex.org/F4320316238","display_name":"Kowa Company","ror":"https://ror.org/009z2z347"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2254036934.pdf","grobid_xml":"https://content.openalex.org/works/W2254036934.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1722951830","https://openalex.org/W1889257304","https://openalex.org/W1972661406","https://openalex.org/W1989589017","https://openalex.org/W1990092121","https://openalex.org/W2001328643","https://openalex.org/W2015836295","https://openalex.org/W2017602185","https://openalex.org/W2040770080","https://openalex.org/W2052341239","https://openalex.org/W2054299101","https://openalex.org/W2058591318","https://openalex.org/W2066568926","https://openalex.org/W2067290544","https://openalex.org/W2070257117","https://openalex.org/W2089110021","https://openalex.org/W2094522465","https://openalex.org/W2096075279","https://openalex.org/W2099654648","https://openalex.org/W2101702589","https://openalex.org/W2107295258","https://openalex.org/W2108169164","https://openalex.org/W2116404316","https://openalex.org/W2127256767","https://openalex.org/W2128030263","https://openalex.org/W2136647159","https://openalex.org/W2141898196","https://openalex.org/W2148577580","https://openalex.org/W2155121555","https://openalex.org/W2157280645","https://openalex.org/W2164346577","https://openalex.org/W2164576143","https://openalex.org/W2166268459","https://openalex.org/W2170888045"],"related_works":["https://openalex.org/W7138011160","https://openalex.org/W1495511625","https://openalex.org/W2526246517","https://openalex.org/W3160892421","https://openalex.org/W2163238468","https://openalex.org/W2886664446","https://openalex.org/W2337214440","https://openalex.org/W2417076517","https://openalex.org/W2922857477","https://openalex.org/W2227479545"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"effect":[2],"of":[3,119,130,151,165],"alirocumab":[4,52,78,106],"on":[5,43],"potentially":[6],"atherogenic":[7,166],"lipoprotein":[8,33,103],"subfractions":[9,104,131],"was":[10,109],"assessed":[11],"in":[12,102,141,168],"a":[13,163],"post":[14],"hoc":[15],"analysis":[16,118],"using":[17,117],"the":[18,127,148],"vertical":[19],"auto":[20],"profile":[21],"(VAP)":[22],"method.":[23],"METHODS:":[24],"Patients":[25],"from":[26,74],"three":[27,89],"Phase":[28],"II":[29],"studies":[30],"with":[31,77,105],"low-density":[32],"cholesterol":[34,128,149],"(LDL-C)":[35],"\u2265":[36],"2.59":[37],"mmol/L":[38],"(100":[39],"mg/dL)":[40],"at":[41,111],"baseline":[42],"stable":[44],"statin":[45,172],"therapy":[46],"were":[47,96,138],"randomised":[48],"to":[49,66,87],"receive":[50],"subcutaneous":[51],"50-150":[53],"mg":[54,61,80],"every":[55,62],"2":[56],"weeks":[57,64],"(Q2W)":[58],"or":[59,68,91,115],"150-300":[60],"4":[63],"(according":[65],"study)":[67],"placebo":[69,92,108],"for":[70],"8-12":[71],"weeks.":[72],"Samples":[73],"patients":[75,169],"treated":[76],"150":[79],"Q2W":[81],"(n":[82,93],"=":[83,94],"74;":[84],"dose":[85],"common":[86],"all":[88],"trials)":[90],"71)":[95],"analysed":[97,110],"by":[98],"VAP.":[99],"Percent":[100],"change":[101],"vs.":[107],"Weeks":[112],"6,":[113],"8":[114],"12":[116],"covariance.":[120],"RESULTS:":[121],"Alirocumab":[122,159],"significantly":[123],"reduced":[124],"LDL-C":[125],"and":[126,134,145,147,155],"content":[129,150],"LDL1,":[132],"LDL2":[133],"LDL3+4.":[135],"Significant":[136],"reductions":[137,161],"also":[139],"observed":[140],"triglycerides,":[142],"apolipoproteins":[143],"CII":[144],"CIII":[146],"very":[152],"low-density,":[153],"intermediate-density,":[154],"remnant":[156],"lipoproteins.":[157],"CONCLUSION:":[158],"achieved":[160],"across":[162],"spectrum":[164],"lipoproteins":[167],"receiving":[170],"background":[171],"therapy.":[173],"TRIAL":[174],"REGISTRATION:":[175],"Clinicaltrials.gov":[176],"identifiers:":[177],"NCT01288443,":[178],"NCT01288469,":[179],"NCT01266876.":[180]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2254036934","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
